| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.9 |
| mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.9 |
| mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |